HL7 Europe Reopens Ballot for Common Cancer Data Model

Details

This article reports that HL7 Europe has reopened a ballot for the Common Cancer Data Model. The purpose of this model is to provide a standardized framework for handling cancer-related data uniformly across Europe. Interoperability of medical data is critically important, especially for patient care and research spanning national borders. By adopting the HL7 standard, it becomes possible to exchange cancer information seamlessly between different systems, contributing to the establishment of a data linkage infrastructure within Europe's digital health strategy (such as the European Health Data Space). Furthermore, related topics visible on this page include "SYNDERAI – Synthetic Data for the European Health Data Space" and "HL7 Europe Working Group Meeting Málaga 2026." These suggest practical information regarding research utilization under privacy protection using synthetic data, and specific event details for large-scale medical data linkage in Europe, reflecting trends in international healthcare IT. The HL7 standard provides the technical foundation—often through modern API-based standards like FHIR—to structure and exchange this complex data. The establishment of a common model in Europe is vital reference information for Japanese hospitals and research institutions participating in international data linkage efforts.